Merck & Co. Inc. buy Guggenheim
Start price
11.04.23
/
50%
€103.40
Target price
11.04.24
€113.61
Performance (%)
13.73%
End price
12.04.24
€117.60
Summary
This prediction ended on 12.04.24 with a price of €117.60. The BUY prediction by Guggenheim finished with a performance of 13.73%. Guggenheim has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €2.77 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 3.611% | 3.611% | -28.407% |
| iShares Core DAX® | -0.099% | 0.273% | 30.094% |
| iShares Nasdaq 100 | -1.085% | 1.502% | 14.195% |
| iShares Nikkei 225® | -0.835% | 3.273% | 5.212% |
| iShares S&P 500 | 0.099% | 1.988% | 10.815% |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Guggenheim from $123.00 to $124.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.60
06.11.24
06.11.24
€121.00
06.11.25
06.11.25
-20.63%
25.08.25
25.08.25
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€83.40
12.02.25
12.02.25
€110.77
12.02.26
12.02.26
-10.90%
25.08.25
25.08.25